{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:06:38Z","timestamp":1772751998450,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00292-018-0475-1","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T12:37:54Z","timestamp":1535632674000},"page":"576-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["(Immun\u2011)Pathologie von Medikamentennebenwirkungen in der Niere","(Immuno\u2011)Pathology of drug side effects in the kidney"],"prefix":"10.1007","volume":"39","author":[{"given":"F.","family":"Pfister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"B\u00fcttner-Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Amann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1091581817752405","volume":"37","author":"WJ Bailey","year":"2018","unstructured":"Bailey WJ, Glaab WE (2018) Accessible miRNA as novel toxicity biomarkers. Int J Toxicol 37:116\u2013120","journal-title":"Int J Toxicol"},{"issue":"1","key":"475_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40425-017-0261-2","volume":"5","author":"L Bottlaender","year":"2017","unstructured":"Bottlaender L, Breton AL, de Laforcade L, Dijoud F, Thomas L, Dalle S (2017) Acute interstitial nephritis after sequential ipilumumab\u2014nivolumab therapy of metastatic melanoma. J\u00a0Immunother Cancer 5(1):57 (Jul)","journal-title":"J Immunother Cancer"},{"issue":"8","key":"475_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3109\/08860220903118590","volume":"31","author":"M Dobre","year":"2009","unstructured":"Dobre M, Wish J, Negrea L (2009) Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a\u00a0case report and literature review. Ren Fail 31(8):745\u2013748","journal-title":"Ren Fail"},{"issue":"6","key":"475_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.semnephrol.2010.09.006","volume":"30","author":"V Eremina","year":"2010","unstructured":"Eremina V, Quaggin SE (2010) Biology of anti-angiogenic therapy-induced thrombotic microangiopathy. Semin Nephrol 30(6):582\u2013590","journal-title":"Semin Nephrol"},{"issue":"11","key":"475_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N\u00a0Engl J Med 358(11):1129\u20131136","journal-title":"N Engl J Med"},{"issue":"2","key":"475_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ekir.2017.10.011","volume":"3","author":"Z Dvanajscak","year":"2017","unstructured":"Dvanajscak Z, Karl BE, Sanchez AP, Walavalkar V (2017) IgA-dominant Glomerulopathy and\u00a0thrombotic Microangiopathy after\u00a0chemotherapy. Kidney Int Rep 3(2):492\u2013497","journal-title":"Kidney Int Rep"},{"issue":"10","key":"475_CR7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00063-007-1104-6","volume":"102","author":"H Haake","year":"2007","unstructured":"Haake H, K\u00f6neke J, Amann K, vom Dahl J, Janssen U (2007) Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis. Med Klin (Munich) 102(10):852\u2013857 (German)","journal-title":"Med Klin (Munich)"},{"issue":"7","key":"475_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2215\/CJN.01910215","volume":"10","author":"JJ Hogan","year":"2015","unstructured":"Hogan JJ, Markowitz GS, Radhakrishnan J (2015) Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol 10(7):1300\u20131310. \n                    https:\/\/doi.org\/10.2215\/CJN.01910215","journal-title":"Clin J Am Soc Nephrol"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ndt\/gfw467","volume":"32","author":"H Izzedine","year":"2017","unstructured":"Izzedine H, Mateus C, Boutros C, Robert C, Rouvier P, Mathian ZAA (2017) Renal effects of immune checkpoint inhibitors. Nephrol Dial Transplant 32:936\u2013942","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"475_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ekir.2017.02.008","volume":"2","author":"H Izzedine","year":"2017","unstructured":"Izzedine H, Perazella MA (2017) Anticancer drug-induced acute kidney injury. Kidney Int Rep 2(4):504\u2013514 (Feb)","journal-title":"Kidney Int Rep"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4049\/jimmunol.1400497","volume":"194","author":"K Jaworska","year":"2015","unstructured":"Jaworska K, Ratajczak J, Huang L, Whalen K, Yang M, Stevens BK, Kinsey GR (2015) Both PD-1 Ligands protect the kidney from Ischemia Reperfusion injury. J\u00a0Immunol 194:325\u2013333","journal-title":"J Immunol"},{"issue":"1","key":"475_CR12","first-page":"3","volume":"9","author":"N Krishnan","year":"2015","unstructured":"Krishnan N, Perazella MA (2015) Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment. Iran J Kidney Dis 9(1):3\u201313","journal-title":"Iran J Kidney Dis"},{"issue":"5","key":"475_CR13","first-page":"337","volume":"66","author":"N Lameire","year":"2011","unstructured":"Lameire N, Kruse V, Rottey S (2011) Nephrotoxicity of anticancer drugs\u2014an underestimated problem? Acta Clin Belg 66(5):337\u2013345","journal-title":"Acta Clin Belg"},{"key":"475_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy105","author":"S Manohar","year":"2018","unstructured":"Manohar S, Kompotiatis P, Thongprayoon C, Cheungpasitporn W, Herrmann J, Herrmann SM (2018) Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis. Nephrol Dial Transplant. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfy105","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"475_CR15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2215\/CJN.00860115","volume":"10","author":"GS Markowitz","year":"2015","unstructured":"Markowitz GS, Bomback AS, Perazella MA (2015) Drug-induced glomerular disease: direct cellular injury. Clin J Am Soc Nephrol 10(7):1291\u20131299. \n                    https:\/\/doi.org\/10.2215\/CJN.00860115","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"475_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2015.115","volume":"88","author":"RL Mehta","year":"2015","unstructured":"Mehta RL, Awdishu L, Davenport A, Murray PT, Macedo E, Cerda J, Chakaravarthi R, Holden AL, Goldstein SL (2015) Phenotype standardization for drug-induced kidney disease. Kidney Int 88(2):226\u2013234","journal-title":"Kidney Int"},{"issue":"1","key":"475_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/his.13064","volume":"70","author":"P Paueksakon","year":"2017","unstructured":"Paueksakon P, Fogo AB (2017) Drug-induced nephropathies. Histopathology 70(1):94\u2013108","journal-title":"Histopathology"},{"issue":"10","key":"475_CR18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.02780312","volume":"7","author":"MA Perazella","year":"2012","unstructured":"Perazella MA (2012) Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 7(10):1713\u20131721","journal-title":"Clin J Am Soc Nephrol"},{"key":"475_CR19","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2018050488","author":"MA Perazella","year":"2018","unstructured":"Perazella MA, Shirali AC (2018) Nephrotoxicity of cancer immunotherapies: past, present and future. J\u00a0Am Soc Nephrol 29(8). \n                    https:\/\/doi.org\/10.1681\/asn.2018050488","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"475_CR20","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1172\/JCI65509","volume":"122","author":"SE Quaggin","year":"2012","unstructured":"Quaggin SE (2012) Turning a\u00a0blind eye to anti-VEGF toxicities. J\u00a0Clin Invest 122(11):3849\u20133851. \n                    https:\/\/doi.org\/10.1172\/JCI65509","journal-title":"J Clin Invest"},{"issue":"7","key":"475_CR21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2215\/CJN.01010115","volume":"10","author":"J Radhakrishnan","year":"2015","unstructured":"Radhakrishnan J, Perazella MA (2015) Drug-induced glomerular disease: attention required! Clin J Am Soc Nephrol 10(7):1287\u20131290","journal-title":"Clin J Am Soc Nephrol"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ncpneph0476","volume":"3","author":"D Roncone","year":"2007","unstructured":"Roncone D, Satoskar A, Nadasdy T, Monk PJ, Rovin BH (2007) Proteinuria in a\u00a0patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Practice 3:287\u2013293","journal-title":"Nat Clin Practice"},{"issue":"2","key":"475_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11560-014-0976-8","volume":"10","author":"C Schmaderer","year":"2015","unstructured":"Schmaderer C, Amann K, Heemann U (2015) Akute tubulointerstitielle Nephritis. Nephrologe 10(2):145\u2013158","journal-title":"Nephrologe"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/ki.2010.97","volume":"78","author":"A Starke","year":"2010","unstructured":"Starke A, Lindenmeyer MT, Segerer S, Neusser MA, R\u00fcsi B, Schmid DM, Cohen CD, W\u00fcthrich RP, Fehr T, Waeckerle-Men Y (2010) Renal tubular PD-L1 (CD274) suppresses alloreactive human T\u2011cell responses. Kidney Int 78:38\u201347","journal-title":"Kidney Int"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41581-018-0003-9","volume":"14","author":"JY Soo","year":"2018","unstructured":"Soo JY, Jansen J, Masereeuw R, Little MH (2018) Advances in predictive in vitro models of drug-induced nephrotoxicity. Nat Rev Nephrol 14:378\u2013393","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"475_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/RHU.0000000000000049","volume":"20","author":"M Suneja","year":"2014","unstructured":"Suneja M, Baiswar S, Vogelgesang SA (2014) Hydralazine associated pauci-immune glomerulonephritis. J\u00a0Clin Rheumatol 20(2):99\u2013102","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"475_CR27","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/ndt\/gfl818","volume":"22","author":"Y Waeckerle-Men","year":"2007","unstructured":"Waeckerle-Men Y, Starke A, W\u00fcthrich RP (2007) PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrol Dial Transplant 22(6):1527\u20131536","journal-title":"Nephrol Dial Transplant"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1756-0500-6-450","volume":"6","author":"M Yahata","year":"2013","unstructured":"Yahata M, Nakaya I, Sakuma T, Sato H, Aoki S, Soma J (2013) Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a\u00a0case report and review of the literature. Bmc Res Notes 6:450","journal-title":"Bmc Res Notes"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-018-0475-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-018-0475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-018-0475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T23:39:23Z","timestamp":1567121963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-018-0475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s00292-018-0475-1","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"30 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Pfister, M.\u00a0B\u00fcttner-Herold und K.\u00a0Amann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}